AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Research

FDA approves Viekira Pak to treat hepatitis C

FDA

The U.S. Food and Drug Administration today approved Viekira Pak (ombitasvir, paritaprevir and ritonavir tablets co-packaged with dasabuvir tablets) to treat patients with chronic hepatitis C virus (HCV) genotype 1 infection, including those with a type of advanced liver disease called cirrhosis. Hepatitis C is a viral disease that causes inflammation of the liver that…

NIH Statement on World AIDS Day 2014

nih logo

Remarkable progress has been made in the fight against HIV/AIDS since the first annual World AIDS Day was commemorated 26 years ago. Yet, we are still far from achieving our goal of a world without AIDS. In 2013, more than 2 million people globally became newly infected with HIV, and 1.5 million people died from…

For an AIDS-Free Generation: Access to Drugs and Diagnostics Is Essential

FDA

On World AIDS Day this year, tens of millions of people with HIV are now living healthy, productive lives because of access to safe and lower priced medicines. We rejoice in this achievement, because all people, no matter how rich or poor, deserve to have the medicines they need to live their lives in the…

Revised Hepatitis C (HCV)/HIV Coinfection Section of the Adult and Adolescent Antiretroviral Treatment Guidelines Released

AIDS.gov

Last week, the HHS Panel on Antiretroviral Guidelines for Adults and Adolescents announced the release of the updated “Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents.” As described in What’s New in the Guidelines, this interim revision of the guidelines features a revised section on Hepatitis C (HCV)/HIV Coinfection that emphasizes…

NIH Launches ClinRegs Website on International Clinical Research Regulations

Capture

An online database of country-specific clinical research regulatory information is now available at clinregs.niaid.nih.gov. Developed by NIH’s National Institute of Allergy and Infectious Diseases (NIAID), the ClinRegs website is designed to help the research community plan international clinical trials more efficiently by consolidating regulatory requirements in one place and enabling comparisons across countries. By providing…

FDA approves first combination pill to treat hepatitis C

FDA

The U.S. Food and Drug Administration today approved Harvoni (ledipasvir and sofosbuvir) to treat chronic hepatitis C virus (HCV) genotype 1 infection. Harvoni is the first combination pill approved to treat chronic HCV genotype 1 infection. It is also the first approved regimen that does not require administration with interferon or ribavirin, two FDA-approved drugs…

Gay and Bisexual Men See HIV as the Top Health Issue Facing Their Community, But Majorities Are Not Personally Worried About Getting Infected & Not Getting Tested Regularly

kff-logo

Most Are Unaware of New Prevention Options, Such as PrEP, or Current Treatment Recommendations MENLO PARK, CA – More than thirty years into the HIV/AIDS epidemic, and at a time when infections among gay and bisexual men are on the rise in the U.S., a new national survey  of gay and bisexual men by the Kaiser Family Foundation…

Puerto Rico Makes Important Strides To Support Vaccine Research to Combat HIV

pr

The Obama Administration is a strong partner in helping Puerto Rico to develop the industries that will support its long-term economic growth. One such opportunity is to work through the President’s Task Force on Puerto Rico to identify opportunities can work more closely with partners to ensure that Puerto Rico’s best days are ahead. Earlier…